With 1.44 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.73 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $206.46 whereas the lowest price it dropped to was $193.79. The 52-week range on UHS shows that it touched its highest point at $243.25 and its lowest point at $127.21 during that stretch. It currently has a 1-year price target of $245.47. With its current market cap of 12.10 billion, UHS has annualized dividend of $0.80 while the current yield stands at 0.39%. Beta for the stock currently stands at 1.30.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of UHS was down-trending over the past week, with a drop of -1.92%, but this was down by -4.23% over a month. Three-month performance dropped to -6.81% while six-month performance rose 20.09%. The stock gained 56.95% in the past year, while it has gained 33.51% so far this year. A look at the trailing 12-month EPS for UHS yields 15.04 with Next year EPS estimates of 18.11. For the next quarter, that number is 4.17. This implies an EPS growth rate of 51.23% for this year and 13.62% for next year. EPS is expected to grow by 24.55% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 4.26%.
Float and Shares Shorts:
At present, 59.93 million UHS shares are outstanding with a float of 56.39 million shares on hand for trading. On 2024-10-15, short shares totaled 1.53 million, which was 229.0 higher than short shares on 1726185600. In addition to Mr. Alan B. Miller as the firm’s Founder & Executive Chairman of the Board, Mr. Marc D. Miller serves as its CEO, President & Director.
Institutional Ownership:
Through their ownership of 0.94935 of UHS’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, UHS reported revenue of $3907604000.0 and operating income of $436398000.0. The EBITDA in the recently reported quarter was $577480000.0 and diluted EPS was $4.26.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for UHS since 13 analysts follow the stock currently. There are 5 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 8 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With UHS analysts setting a high price target of 275.0 and a low target of 211.0, the average target price over the next 12 months is 245.34. Based on these targets, UHS could surge 35.12% to reach the target high and rise by 3.68% to reach the target low. Reaching the average price target will result in a growth of 20.55% from current levels.
Analysts have provided yearly estimates in a range of $16.31512 being high and $15.47228 being low. For UHS, this leads to a yearly average estimate of $15.94387. The surprise factor in the prior quarter was $3.28. Based on analyst estimates, the high estimate for the next quarter is $4.61 and the low estimate is $3.92. The average estimate for the next quarter is thus $4.23.
